BBLG (STOCKS)
Bone Biologics Corp Common Stock
$1.221700
-0.038300 (-3.04%)
Prev close: $1.260000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Jeffrey Frelick
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2.21M
- Employees
- 2
- P/E (TTM)
- -0.32
- P/B (TTM)
- 0.42
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.14 | $-0.35 | +0.2068 | +59.63% |
|
Sep 2025 (Q3)
|
$-0.37 | $-1.25 | +0.8846 | +70.51% |
|
Jun 2025 (Q2)
|
$-1.33 | $-0.59 | -0.7384 | -124.81% |
|
Mar 2025 (Q1)
|
$-1.92 | $-2.94 | +1.0176 | +34.64% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $125.95K |
| Operating Expenses | $3.23M |
| Research and Development | $1.06M |
| Other Operating Expenses | $2.17M |
| Operating Income/Loss | -$3.23M |
| Income/Loss From Continuing Operations After Tax | -$3.10M |
| Income/Loss From Continuing Operations Before Tax | -$3.10M |
| Net Income/Loss | -$3.10M |
| Net Income/Loss Attributable To Noncontrolling Interest | $8.99K |
| Net Income/Loss Attributable To Parent | -$3.11M |
| Net Income/Loss Available To Common Stockholders, Basic | -$3.11M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.65 |
| Diluted Earnings Per Share | -$2.65 |
| Basic Average Shares | 1,174,869 |
| Diluted Average Shares | 1,174,869 |
| Assets | $5.80M |
| Current Assets | $5.80M |
| Prepaid Expenses | $10.00K |
| Other Current Assets | $5.79M |
| Noncurrent Assets | $0.00 |
| Liabilities | $418.59K |
| Current Liabilities | $418.59K |
| Noncurrent Liabilities | $0.00 |
| Equity | $5.38M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $5.38M |
| Liabilities And Equity | $5.80M |
| Net Cash Flow From Operating Activities | -$2.69M |
| Net Cash Flow From Operating Activities, Continuing | -$2.69M |
| Net Cash Flow From Investing Activities | -$2.01M |
| Net Cash Flow From Investing Activities, Continuing | -$2.01M |
| Net Cash Flow From Financing Activities | $4.70M |
| Net Cash Flow From Financing Activities, Continuing | $4.70M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$3.10M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$3.10M |
| Other Comprehensive Income/Loss | $0.00 |